A new study from The University of Texas at Arlington has revealed how cells control their mitochondria—the "energy producers ...

Scientists are hoping to treat diseases including cancer and Alzheimer's by influencing how cells make life-or-death ...

If approved in RCC, fruquintinib will be available for three indications, including endometrial and colorectal cancer.

Programmed cell death is an essential part of a healthy, normal life as the body removes old, damaged or unnecessary cells.

HIV remains a major global health issue, affecting nearly 40 million people worldwide. Current treatments, known as antiretroviral therapy (ART), are highly effective at suppressing the virus and ...

Researchers sought to determine whether isatuximab and cemiplimab would be safe and effective for patients with relapsed/refractory extranodal NK/T-cell lymphoma.

Scientists at La Trobe University have discovered a previously unknown way viruses could spread around the body, potentially ...

The US Food and Drug Administration (FDA) has granted approval to Regeneron Pharmaceuticals’ fully human monoclonal antibody ...

From bispecific engineering to clinically relevant data sourcing, evolving antibody technologies advance oncology therapeutics.

Gilead and Arcus Bioscience’s monoclonal antibody (mAb), domvanalimab, has produced positive results in a Phase II ...

BPGbio has completed phase 2b enrollment in late August this year for treatment of GBM with BPM31510Data further validate the MOA of BPM31510’s ...